Jdm Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 105.19%
(FY 2023)
- Profit 6662.47%
(FY 2023)
- Ebitda 3800.62%
(FY 2023)
- Net Worth 60.68%
(FY 2023)
- Total Assets 99.80%
(FY 2023)
About Jdm Pharma Solutions
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Daleep Malhotra, Jigneshkumar Patel, Manoharan Pillai, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100GJ2015PTC083603
- Company No.
083603
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jdm Pharma Solutions?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigneshkumar Patel  | Director | 19-Jun-2015 | Current |
| Daleep Malhotra | Additional Director | 01-Oct-2024 | Current |
| Manoharan Pillai | Director | 19-Jun-2015 | Current |
| Bipinchandra Patel | Additional Director | 01-Oct-2024 | Current |
| Sanjeev Misra | Additional Director | 01-Oct-2024 | Current |
Financial Performance of Jdm Pharma Solutions.
Jdm Pharma Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 105.19% increase. The company also saw a substantial improvement in profitability, with a 6662.47% increase in profit. The company's net worth Soared by an impressive increase of 60.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jdm Pharma Solutions?
Unlock access to Jdm Pharma Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Elixir Pharma Chem Private LimitedActive 1 year 6 monthsJigneshkumar Patel and Bipinchandra Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jdm Pharma Solutions?
Unlock and access historical data on people associated with Jdm Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jdm Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jdm Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
